Bioxytran Competitors and Similar CompaniesClear all
Versantis's competitors and similar companies include Cellis and IMIDomics.
 Versantis Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. |  Cellis Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology. |  IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date 2015 | Founding Date 2015 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Zürich, CH HQ | Locations Zürich, CH HQ Warsaw, PL | Locations HQ |
Employees | Employees 2 | Employees 23 | Employees 3 |
Funding | |||
Latest funding round | Latest funding round $ 16.1m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 16.5m (almost 5 years ago) |
Total funding raised | Total funding raised $ 20.7m | Total funding raised N/A | Total funding raised $ 16.5m |
For sources of this data, please see the company profile
View Company Profiles
Cellis
HQ
Zürich, CH
Employees
23
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
View companyIMIDomics
HQ
Employees
3
IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company